India formally approved the Oxford-AstraZeneca on Sunday COVID-19 vaccine for emergency use. The vaccine, made in India by the Serum Institute, was first approved by Britain this week. This is all you need to know about the vaccine called Covishield in India. HOW DOES THE EFFECTIVENESS OF ASTRAZENECA SHOT APPEAR …
Read More »Covid-19: Congressional questions nod to Covaxin; BJP Strikes Back | India News
NEW DELHI: Several Congressional leaders on Sunday raised questions about the approval process for Bharat Biotech’s Covid-19 vaccine, saying the “premature” step can prove to be “dangerous.” The government and the BJP responded vigorously to criticism from Congress, and BJP chief JP Nadda said the opposition party comes up with …
Read More »Covishield IBS Approval – Efficacy, Cost, and All About AstraZeneca’s Covid-19 Vaccine
A government panel of experts reportedly approved the vaccine, developed by AstraZeneca and the University of Oxford, for emergency use in India to provide immunity against coronavirus disease (Covid-19). According to the Reuters news agency, a committee of experts in the field, created by the Comptroller General of Drugs of …
Read More »US hopes to approve UK-backed AstraZeneca-Oxford vaccine in April
The United States is expected to approve the low-cost AstraZeneca / Oxford vaccine in April. Washington, United States: The United States is expected to approve the low-cost AstraZeneca / Oxford vaccine in April, a senior official said, more than three months after Britain’s green light on Wednesday. Moncef Slaoui, the …
Read More »Why is approval of the AstraZeneca Covid-19 vaccine ‘good news for everyone’? UK Minister’s Response
After British regulators approved AstraZeneca’s vaccine to provide immunity against the coronavirus disease (Covid-19) on Wednesday, British Health Minister Matt Hancock said the approval was “good news for everyone.” Speaking to Sky News, Hancock highlighted the advantages of the AstraZeneca vaccine, developed at the University of Oxford, over other Covid-19 …
Read More »Covid-19: Oxford vaccine may receive approval in a few days | India News
NEW DELHI: India is likely to see the Oxford-AstraZeneca vaccine approved for emergency use in the coming days, as updated data presented by the Serum Institute of India (SII) appears “satisfactory,” top government sources said. Once the data assessment is complete, the regulator may not wait for the vaccine to …
Read More »Oxford vaccine: India will likely approve AstraZeneca vaccine next week | India News
NEW DELHI: India is likely to approve the Oxford / AstraZeneca coronavirus vaccine for emergency use next week after its local manufacturer submitted additional data requested by authorities, two sources with knowledge of the matter told Reuters on Tuesday. This could be the first country to give a regulatory green …
Read More »Covid-19 vaccine updates: US to receive millions of doses starting Monday, Peru suspends trials of China’s vaccine – health
The new coronavirus (Covid-19) pandemic, which began nearly a year ago, has infected more than 72 million people and killed 1.6 million so far, according to worldometer figures. Several governments around the world, in collaboration with pharmaceutical companies, have carried out extensive work to develop vaccines that can eliminate this …
Read More »Serum Institute Will Probably Supply Covid Vaccine At Rs 250 Per Dose – Report
The government is pinning its hopes for a massive supply of vaccines to the Serum Institute. (Figurative) Bangalore: The Serum Institute of India, the world’s largest producer of vaccines by volume, is close to signing a supply contract with the Center and will likely set prices at Rs 250 ($ …
Read More »Drug Controller Likely to Answer Call for AstraZeneca’s Emergency Use, Pfizer’s Covid-19 Vaccines in 2 Weeks
Drug Controller Likely to Take AstraZeneca Emergency Use Call, Pfizer’s COVID-19 Vaccinations in 2 weeks The Comptroller General of Drugs of India has started to process applications submitted by Pfizer Inc and Serum Institute of India to grant emergency use authorization to their COVID-19 vaccinations and is likely to make …
Read More »